13 Best Forever Stocks to Buy Right Now

11. DaVita Inc. (NYSE:DVA)

Number of Hedge Fund Holders: 39

DaVita Inc. (NYSE:DVA) provides renal dialysis treatments to individuals suffering from chronic kidney failure in the United States. The firm runs renal dialysis clinics and offers associated lab services at outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services and manages clinical laboratories that conduct standard laboratory testing for dialysis.

In the third quarter of 2024, the company recorded consolidated revenues of $3.2 billion. Furthermore, operating income was $535 million, demonstrating the company’s capacity to profit from its core businesses while eliminating non-operational costs such as taxes and interest. Additionally, diluted profits per share was $2.50, while adjusted diluted earnings per share was $2.59. With 2028 as the nearest maturity date, DaVita Inc. (NYSE:DVA) has properly controlled its debt, and its leverage is within acceptable limits.

DaVita Inc. (NYSE:DVA) managed recent operational challenges well, reducing the impact of storms and maintaining labor and medical cost management. The company anticipates supply chain circumstances to return to normal by early 2025 as it prepares for a regulatory move involving oral-only pharmaceuticals into Medicare Part B, which may increase patient access and efficiency.